(Q74475086)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12122863%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Alcoholic and nonalcoholic steatohepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12122863%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1

Elizabeth M Brunt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12122863%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12122863%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

published in

Clinics in liver disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12122863%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12122863%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12122863%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

399-420, vii

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12122863%20AND%20SRC:MED&resulttype=core&format=json

Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Recurrence of nonalcoholic steatohepatitis following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic steatohepatitis: definition and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Pathology of alcoholic liver disease. VA Cooperative Study Group 119.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Histologic spectrum of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

SCLEROSING HYALINE NECROSIS OF THE LIVER IN THE CHRONIC ALCOHOLIC. A RECOGNIZABLE CLINICAL SYNDROME

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Hemosiderosis in cirrhosis: a study of 447 native livers

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Hemochromatosis: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Fatty liver hepatitis and cirrhosis in obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Hepatic lesions of central pericellular fibrosis in morbid obesity, and after jejunoileal bypass

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Post-jejunoileal-bypass Hepatic Disease: Its Similarity to Alcoholic Hepatic Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

The pathology of diabetic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Pattern of progression in liver injury following jejunoileal bypass for morbid obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Idiopathic steatohepatitis in childhood: a multicenter retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic steatohepatitis: a study of 49 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Two cases from the spectrum of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Clinical features and natural history of nonalcoholic steatosis syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic Steatohepatitis in Children

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

The pathology of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic steatohepatitis: an evolving diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Mitochondria in steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Review: nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Ultrastructural findings on polymorphonuclear leucocyte infiltration and acute hepatocellular damage in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Mallory bodies revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Apoptosis and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Mitochondrial abnormalities in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Chronic liver disease: do alcohol and hepatitis C virus interact

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Perisinusoidal fibrosis and basement membrane-like material in the livers of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Liver fibrosis in overweight patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Early perivenular fibrogenesis--precirrhotic lesions among moderate alcohol consumers and chronic alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Etiopathogenesis of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Alcoholic liver disease: natural history

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Non-alcoholic steatohepatitis: another disease of affluence

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Body composition and hepatic steatosis as precursors for fibrotic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic steatohepatitis: a toxic liver disease in industrial workers

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Non-alcoholic fatty liver: another feature of the metabolicsyndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Insulin resistance and mitochondrial abnormalities in NASH: a cool look into a burning issue.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Liver pathology and the metabolic syndrome X in severe obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Treatment of nonalcoholic fatty liver: present and emerging therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Diabetes mellitus and the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

More clues to the relationship between hepatic iron and steatosis: An association with insulin resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Insulin resistance-associated hepatic iron overload.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

NASH: Can we iron out the pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Hepatic iron and nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Nonalcoholic Steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Hepatic steatosis: innocent bystander or guilty party?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Is bacterial ash the flash that ignites NASH?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Peroxisomal beta-oxidation and steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900002-8

7 January 2021

10.1016/S1089-3261(02)00002-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12122863%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference